Journal of the Renin-Angiotensin-Aldosterone System (JRAAS)

The Journal of the Renin‑Angiotensin‑Aldosterone System (JRAAS) is a respected scholarly journal dedicated to advancing understanding of the renin‑angiotensin‑aldosterone system (RAAS) — a central regulator of blood pressure, fluid balance, and cardiovascular homeostasis. Since its inception in 2000, JRAAS has been published quarterly, offering a curated forum for rigorous, peer‑reviewed research that spans basic science, translational investigation, and clinical applications related to RAAS biology and pathology. The RAAS plays a pivotal role in common and complex conditions such as hypertension, heart failure, chronic kidney disease, diabetes‑associated vascular complications, and endocrine disorders, and is a major target of therapeutic strategies worldwide. JRAAS publishes original research articles that elucidate molecular and cellular mechanisms, as well as reviews that synthesize current evidence on RAAS signaling, receptor physiology, peptidergic regulation, and pharmacological modulation. Articles in the journal often evaluate novel drug targets, receptor interactions, systemic effects in non‑cardiovascular tissues, and emerging insights in RAAS‑related therapies, bridging laboratory discoveries with clinical relevance. The journal’s global editorial board fosters scientific excellence by ensuring methodological rigor, relevance, and ethical publication practices. Indexed in key biomedical databases and widely referenced in cardiovascular and endocrine research, JRAAS provides an essential resource for researchers, clinicians, and pharmacologists exploring one of physiology’s most influential hormonal cascades.

Journal of the Renin-Angiotensin-Aldosterone System (JRAAS) is :-

• International, Peer-Reviewed, Open Access, Refereed, Biochemistry, Genetics and Molecular Biology (miscellaneous), Internal Medicine, clinical investigation, pharmacology, heart failure, kidney disease, vascular remodeling, endocrine regulation, organ‑specific mechanistic pathways. , Online or Print , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1470-3203, E-ISSN: 1752-8976, Established: 2000, Impact Factor: 4.1
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE